Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 18-08-2026
NAV ₹16.82(R) +0.32% ₹17.58(D) +0.33%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 19.79% -% -% -% -%
Direct 21.86% -% -% -% -%
Nifty Pharma TRI 19.79% 20.76% 14.22% 20.01% 9.35%
SIP (XIRR) Regular 34.9% -% -% -% -%
Direct 37.15% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr
Top Pharma Fund
Fund Name Rank Rating
- -
- -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 18-08-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 16.82
0.0500
0.3200%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 17.58
0.0600
0.3300%

Review Date: 18-08-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.18 1.47
2.40
-0.94 | 4.92 5 | 15 Good
3M Return % 11.97 6.83
9.60
3.83 | 13.45 6 | 15 Good
6M Return % 21.85 17.39
18.93
12.45 | 24.12 5 | 15 Good
1Y Return % 19.79 19.79
15.88
7.31 | 24.04 5 | 14 Good
1Y SIP Return % 34.90
28.02
11.18 | 39.42 5 | 14 Good
Return data last Updated On : Aug. 18, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.33 1.47 2.50 -0.88 | 5.06 5 | 15 Good
3M Return % 12.45 6.83 9.98 4.01 | 13.93 6 | 15 Good
6M Return % 22.88 17.39 19.78 12.93 | 25.09 5 | 15 Good
1Y Return % 21.86 19.79 17.53 8.18 | 25.46 5 | 14 Good
1Y SIP Return % 37.15 29.79 12.63 | 41.54 5 | 14 Good
Return data last Updated On : Aug. 18, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
18-08-2026 16.823 17.579
17-08-2026 16.77 17.522
14-08-2026 16.782 17.533
13-08-2026 16.829 17.581
12-08-2026 16.873 17.626
11-08-2026 16.946 17.701
10-08-2026 16.823 17.572
07-08-2026 16.722 17.464
06-08-2026 16.679 17.419
05-08-2026 16.634 17.37
04-08-2026 16.601 17.336
03-08-2026 16.565 17.298
31-07-2026 16.554 17.284
30-07-2026 16.487 17.212
29-07-2026 16.529 17.256
28-07-2026 16.344 17.062
27-07-2026 16.374 17.092
24-07-2026 16.079 16.781
23-07-2026 16.08 16.782
22-07-2026 16.18 16.885
21-07-2026 16.364 17.077
20-07-2026 16.304 17.013

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.